Barron’s couldn’t be more wrong when it says you can’t know the winners of cannabis legalization – and this winning stock proves it…
“Forget Pot, Crypto, and SPACs. Why Pros Say Retirement Savers Should Avoid Fads”
That was the headline of a July 24 report from Barron’s, a sister publication of the Wall Street Journal that was founded in 1921 – one I immediately took issue with.
If you’re reading this right now, like me, you believe cannabis is more than just a “fad.”
In a 2020 Gallup poll, 68% of Americans surveyed said they support cannabis legalization, the highest percentage ever in the poll’s history. Medical cannabis is legal in 37 states – or 74% of the country.
So cannabis investing should not be presented as a short-lived craze.
Now, one of the few points I did agree with was that the article said retirees should never invest what they can’t afford to lose. That advice extends past retirees. Because if you need money to pay a car bill or mortgage on time, you shouldn’t be using that money for investments.
That’s fair enough.
But what really got under my skin was the advice from a financial planner quoted in the report.
“Even if marijuana is legalized at the federal level, it’s hard to predict which companies will succeed.”
I only have one thing to say to that.
In fact, the incorrect objection that there aren’t any clear-cut winners in cannabis is one I hear so much that I tore it down in my guide, Busting the 5 Biggest Myths and Misconceptions of Cannabis Investing.
Because at the National Institute for Cannabis Investors (NICI), we are the authority on cannabis investing, and we know who the winners will be as cannabis prohibition comes to an end. As I’ve said before, it may feel like a roller coaster right now, but if you stay on the ride, you will be rewarded.
You just need someone to help you navigate the most profitable opportunities.
That’s why we’re here.
Not everyone can see who the winners will be, but I can.
One Cannabis Stock That Should Be in Every Portfolio
Over the next decade in the United States, walking into a dispensary to buy a pack of pre-rolled joints will be just as commonplace as it is to buy a six-pack of beer from the liquor store.
Curaleaf Holdings Inc.‘s (OTC: CURLF) chairman, Boris Jordan, knows that, and he plans ahead to make sure his company is in the best position to make the most money – considering cannabis is expected to become a $42.9 billion market in the U.S. by 2025.
Curaleaf wants to reach the 93% to 95% of U.S. households that don’t currently consume cannabis. To do so, it plans to eventually become just a processor and manufacturer of cannabis products.
This will not only cut out the cost of grow operations, but it will allow the company to focus more on its branding in order to stand out from the crowd.
“We’re making the products much more mainstream for our customer base – we’ll be no different than Coca-Cola or Frito-Lay,” Jordan said in an interview with Forbes.
The company already has operations in 23 states with a total of over 100 dispensaries, making it one of the largest multistate operators (MSOs) out there right now.
That’s a good start toward reaching the 93% to 95% of U.S. households that aren’t currently consuming cannabis.
Curaleaf also bought the largest vertically integrated cannabis company in Europe – EMMAC Life Sciences Limited – for $286 million. Europe was only a $359 million legal cannabis market in 2020, but Curaleaf CEO Joseph Bayern believes it could eventually be a market worth $120 billion.
Before that happens, Curaleaf is wisely building an American (and European) footprint so that it can capture the biggest share of those sales…which could make you a lot of money if you’re wise enough to get in on CURLF stock now.
NICI Membership subscribers had the chance to get in early on Curaleaf and are already looking at 70% gains, thanks to our real-time profit alerts and trade recommendations.
Those gains are only just the tip of the iceberg. And there are plenty of other winners to stack your portfolio with profits.
So don’t wait around and miss this chance to maximize your returns on the rest of the top-performing stocks in our model portfolio.
Remember – Coca-Cola didn’t build an empire by just selling drinks in the U.S. It did so by building a global brand.
And just like Coca-Cola and Starbucks, Curaleaf will be everywhere potential customers are.
To your investing success,
Partner, RADD Capital
2 responses to “Barron’s Says You Can’t Know the Winners of Cannabis Legalization. It Couldn’t Be More Wrong – And This Winning Stock Proves It.”
August 03 2021